02029nam a2200361 4500 7554 9291681237 7554 20020716d2002 y0pory50 ba eng Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs European Monitoring Centre for Drugs and Drug Addiction Luxembourg Office for Official Publications of the European Communities 2002 116 p. il. 21 cm Implemention of the joint action 3 Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https://www.emcdda.org Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on ketamine in accordance with Article 3 of the joint action of 16 june 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of ketamine in human medicine in the EU Member States. Use of ketamine in veterinary medicine in the EU Member States. Review of the pharmacotoxicological data on ketamine. Sociological and criminological (Europol) evidence. Public health risks - epidemiological evidence. DROGAS ILÍCITAS 6631 SUBSTÂNCIAS PSICOTRÓPICAS 6333 COOPERAÇÃO INTERNACIONAL 581 SAÚDE PÚBLICA 1370 MEDICINA 1408 EUROPOL 103050 CONSELHO DA EUROPA 6334 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA 5764 DRO320 0 DRO_320_000000000000000 2021-12-17 4384 10337 DGRSP DGRSP DGRSP4384501363 DRO320 2021-12-17 0 MO oferta